Abstract

We have systematically investigated how vascular smooth muscle α 1‐adrenoceptor activation impacts endothelium‐mediated vasodilation in isolated, myogenically active, rat cremaster muscle 1A arteries. Cannulated cremaster arteries were pressurized intraluminally to 70 mmHg to induce myogenic tone, and exposed to vasoactive agents via bath superfusion at 34°C. Smooth muscle membrane potential was measured via sharp microelectrode recordings in pressurized, myogenic arteries. The α 1‐adrenergic agonist phenylephrine (25–100 nmol/L) produced further constriction of myogenic arteries, but did not alter the vasorelaxant responses to acetylcholine (0.3 μmol/L), SKA‐31 (an activator of endothelial Ca2+‐dependent K+ channels) (3 μmol/L) or sodium nitroprusside (10 μmol/L). Exposure to 0.25–1 μmol/L phenylephrine or 1 μmol/L norepinephrine generated more robust constrictions, and also enhanced the vasodilations evoked by acetylcholine and SKA‐31, but not by sodium nitroprusside. In contrast, the thromboxane receptor agonist U46619 (250 nmol/L) dampened responses to all three vasodilators. Phenylephrine exposure depolarized myogenic arteries, and mimicking this effect with 4‐aminopyridine (1 mmol/L) was sufficient to augment the SKA‐31‐evoked vasodilation. Inhibition of L‐type Ca2+ channels by 1 μmol/L nifedipine decreased myogenic tone, phenylephrine‐induced constriction and prevented α 1‐adrenergic enhancement of endothelium‐evoked vasodilation; these latter deficits were overcome by exposure to 3 and 10 μmol/L phenylephrine. Mechanistically, augmentation of ACh‐evoked dilation by phenylephrine was dampened by eNOS inhibition and abolished by blockade of endothelial KCa channels. Collectively, these data suggest that increasing α 1‐adrenoceptor activation beyond a threshold level augments endothelium‐evoked vasodilation, likely by triggering transcellular signaling between smooth muscle and the endothelium. Physiologically, this negative feedback process may serve as a “brake” to limit the extent of vasoconstriction in the skeletal microcirculation evoked by the elevated sympathetic tone.

Highlights

  • Changes in tissue blood flow are largely dependent upon the intraluminal diameter of small resistance arteries, which is jointly controlled by the myogenic reactivity of vascular smooth muscle, vasoactive molecules generated in the adjacent endothelium and the activity of sympathetic nerves innervating the arterial wall (Segal 2005; Bagher and Segal 2011; Westcott and Segal 2013)

  • The results of our study demonstrate the a1-adrenergic agonists phenylephrine and noradrenaline, but not the thromboxane receptor agonist U46619, significantly enhanced endothelium-dependent vasodilation in response to acetylcholine (ACh) and the KCa channel activator SKA-31, whereas the vasodilatory response to sodium nitroprusside was unaffected in the presence of a1-adrenoceptor activation

  • When normalized to the total amount of active myogenic constriction generated in these arteries (85.6 Æ 8.7 lm, n = 67), the percentage inhibition of myogenic tone evoked by ACh, SKA-31 and sodium nitroprusside (SNP) was calculated to be 65.2%, 55.1% and 54.7%, respectively

Read more

Summary

Introduction

Changes in tissue blood flow are largely dependent upon the intraluminal diameter of small resistance arteries, which is jointly controlled by the myogenic reactivity of vascular smooth muscle, vasoactive molecules generated in the adjacent endothelium and the activity of sympathetic nerves innervating the arterial wall (Segal 2005; Bagher and Segal 2011; Westcott and Segal 2013). We have hypothesized that concurrent a1-adrenoceptor activation will either positively or negatively influence endothelium-dependent vasodilation, and this impact will depend upon the degree of a1-adrenoceptor activation (i.e., magnitude/direction of effect driven by the concentration of a1-adrenoceptor agonist) This hypothesis was examined by investigating the influence of VSM a1-adrenoceptor activation on the regulation of intraluminal diameter by endotheliumdependent vasodilators in isolated, myogenically active rat skeletal muscle arteries. Such qualitative effects would be observed as a quantitative enhancement or impairment of evoked, endothelium-dependent vasodilation in the presence vs the absence of a1-adrenoceptor activation. Such a1-mediated effects on endothelial function could arise from altered intracellular Ca2+ signaling (Dora et al 1997; Yashiro and Duling 2000; Isakson et al 2007), and/or responsiveness of VSM to vasoactive signals from the endothelium (e.g., changes in the sensitivity of VSM to endothelium-derived signals)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call